journal
Journals Travel Medicine and Infectious...

Travel Medicine and Infectious Disease

https://read.qxmd.com/read/36933851/effectiveness-of-the-bbibp-corv-vaccine-in-preventing-infection-and-death-in-health-care-workers-in-peru-2021
#1
JOURNAL ARTICLE
Javier Silva-Valencia, Percy Soto-Becerra, Stefan Escobar-Agreda, Manuel Fernández-Navarro, Miguel Moscoso-Porras, Lely Solari, Percy Mayta-Tristán
BACKGROUND: During 2021, Peru started the vaccination against SARS-CoV-2 using the BBIBP-CorV inactivated virus vaccine for health care workers (HCW). We aim to evaluate the effectiveness of the BBIBP-CorV vaccine to prevent SARS-CoV-2 infection and deaths among HCWs. METHODS: Retrospective cohort study, from February 9 to June 30, 2021, using national registries of health care workers, laboratory tests for SARS-CoV-2 and deaths. We calculated the vaccine effectiveness for preventing laboratory-confirmed SARS-CoV-2 infection, COVID-19-mortality, and all-cause mortality among partially immunized and fully immunized HCWs...
March 16, 2023: Travel Medicine and Infectious Disease
https://read.qxmd.com/read/36913993/fever-with-perinasal-and-tongue-lesions-a-diagnostic-challenge
#2
JOURNAL ARTICLE
Luca Pipitò, Bianca Catania, Marcello Trizzino, Vito Rodolico, Antonio Cascio
The diagnosis may be challenging, and high suspicion index should be maintained in immunosuppressed patients with unusual mucocutaneous lesions, even in non-endemic areas for mucocutaneous leishmaniasis.
March 11, 2023: Travel Medicine and Infectious Disease
https://read.qxmd.com/read/36898490/factors-associated-with-not-receiving-the-primary-series-and-booster-dose-of-the-covid-19-vaccine-among-venezuelan-migrants-in-peru-a-population-based-cross-sectional-study
#3
JOURNAL ARTICLE
Ali Al-Kassab-Córdova, Claudia Silva-Perez, Carolina Mendez-Guerra, Percy Herrera-Añazco, Vicente Benites-Zapata
BACKGROUND: Ensuring broad COVID-19 vaccination coverage among migrants is a global public health concern. Thus, our study aimed to assess the factors associated with not receiving the primary series and booster doses of the COVID-19 vaccine among Venezuelan migrants in Peru. METHODS: This was a cross-sectional study based on secondary data analysis of the 2022 Venezuelan Population Residing in Peru Survey. Our population included Venezuelan migrants and refugees over 18 years old living in Peru with complete information for the variables of interest...
March 8, 2023: Travel Medicine and Infectious Disease
https://read.qxmd.com/read/36898489/lepromatous-nodular-syphilis-a-case-from-italy
#4
LETTER
Luca Pipitò, Marcello Trizzino, Elisabetta Orlando, Cinzia Calà, Antonio Cascio
No abstract text is available yet for this article.
March 8, 2023: Travel Medicine and Infectious Disease
https://read.qxmd.com/read/36822386/differences-in-cycle-threshold-values-in-rt-pcr-tests-between-children-and-adults-with-monkeypox-results-from-a-community-based-cross-sectional-study
#5
LETTER
Paulo Ricardo Martins-Filho, Fernanda Cardoso Menezes Dorea, Gabriela Vasconcelos Brito Bezerra, Cliomar Alves Dos Santos
No abstract text is available yet for this article.
February 21, 2023: Travel Medicine and Infectious Disease
https://read.qxmd.com/read/36813073/cycle-threshold-values-are-not-associated-with-mortality-risk-factor-analysis-in-older-patients-with-the-sars-cov-2-omicron-variant
#6
LETTER
Ya Wu, Yunhai Feng, Jing Wan, Wei Du, Minfang Tao, Shuiming Gu, Jun Yin
No abstract text is available yet for this article.
February 20, 2023: Travel Medicine and Infectious Disease
https://read.qxmd.com/read/36805033/surge-of-mucormycosis-during-the-covid-19-pandemic
#7
REVIEW
Paulami Dam, Marlon H Cardoso, Sukhendu Mandal, Octávio L Franco, Pınar Sağıroğlu, Osman Ahmet Polat, Kerem Kokoglu, Rittick Mondal, Amit Kumar Mandal, Ismail Ocsoy
Patients with respiratory viral infections are more likely to develop co-infections leading to increased fatality. Mucormycosis is an epidemic amidst the COVID-19 pandemic that conveys a 'double threat' to the global health fraternity. Mucormycosis is caused by the Mucorales group of fungi and exhibits acute angioinvasion generally in immunocompromised patients. The most familiar foci of infections are sinuses (39%), lungs (24%), and skin tissues (19%) where the overall dissemination occurs in 23% of cases...
February 20, 2023: Travel Medicine and Infectious Disease
https://read.qxmd.com/read/36809829/monkeypox-clinical-disease-literature-review-and-a-tool-proposal-for-the-monitoring-of-cases-and-contacts
#8
JOURNAL ARTICLE
Emilie Javelle, Cécile Ficko, Hélène Savini, Marie Mura, Olivier Ferraris, Jean Nicolas Tournier, Franck de Laval
The human monkeypox disease has mainly been described in Western and Central Africa. Since May 2022, the monkeypox virus has been spreading worldwide in a new epidemiological pattern, where cases result from person-to-person transmission, and develop clinically milder or less typical illness than during previous outbreaks in endemic areas. The newly-emerging monkeypox disease needs to be described over the long term, to improve cases definitions, to implement prompt control measures against epidemics, and to provide supportive care...
February 19, 2023: Travel Medicine and Infectious Disease
https://read.qxmd.com/read/36805034/improving-the-mental-health-of-lesbian-gay-bisexual-transgender-queer-intersex-and-asexual-lgbtqia-community-through-counseling-and-rehabilitation-measures-during-monkey-pox-disease-outbreak
#9
LETTER
Vishnu Priya Veeraraghavan, Jyotsna Needamangalam Balaji, Sreenidhi Prakash, Lavina Prashar, Ullas Mony, Krishna Mohan Surapaneni
No abstract text is available yet for this article.
February 16, 2023: Travel Medicine and Infectious Disease
https://read.qxmd.com/read/36805032/global-border-restrictions-in-2020-2021-adherence-and-the-effectiveness-in-long-term-covid-19-epidemic-control
#10
JOURNAL ARTICLE
Zhiyao Li, Boran Yang, Jiale Wang, Yanchao Wen, Jianguo Xu, Li Ling, Tong Wang
BACKGROUND: Restrictions on international travel were widely applied to contain cross-border COVID-19 diffusion, while such applications varied globally, and little was known about their impacts on the long-term epidemic progression. METHODS: We explored the global diversity in maintaining border policies classified to four levels (screening, quarantine, ban on regions and total border closure) using data of 185 countries and regions between 01 January 2020 to 31 December 2021...
February 16, 2023: Travel Medicine and Infectious Disease
https://read.qxmd.com/read/36805019/cognitive-dysfunction-diabetes-mellitus-2-and-arterial-hypertension-sequelae-up-to-one-year-of-covid-19
#11
JOURNAL ARTICLE
Miguel Á Fernández-Ortega, Efrén R Ponce-Rosas, Daniel A Muñiz-Salinas, Omar Rodríguez-Mendoza, Paola Nájera Chávez, Verónica Sánchez-Pozos, Rocío Dávila-Mendoza, Alan E Barrell
BACKGROUND: Covid symptoms reflect its multisystem nature, in addition to its positive relationship between the severity of the condition and the severity of the long COVID. OBJECTIVE: To identify the factors associated with the prevalence of SEQUELAE DUE TO COVID-19 one year after their hospital discharge due to severe pneumonia. METHOD: Longitudinal, analytical, prospective and comparative study. 71 covid-19 pneumonia survivors were followed...
February 15, 2023: Travel Medicine and Infectious Disease
https://read.qxmd.com/read/36792022/artemether-lumefantrine-mefloquine-and-atovaquone-proguanil-in-the-treatment-of-uncomplicated-plasmodium-falciparum-malaria-in-travellers-a-retrospective-comparative-study-of-efficacy-and-treatment-failures
#12
JOURNAL ARTICLE
Vyacheslav Grebenyuk, František Stejskal, Eva Nohýnková, Ivana Zicklerová, Lenka Richterová, Hana Roháčová, Hanuš Rozsypal, Milan Trojánek
BACKGROUND: The aim of this study was to evaluate the rates of parasitaemia clearance and the prevalence of treatment failure in patients with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (AL), mefloquine (MQ), and atovaquone-proguanil (AP). METHOD: The retrospective descriptive study included adult patients with uncomplicated P. falciparum malaria treated at the University Hospital Bulovka in Prague from 2006 to 2019. Parasitaemia clearance was estimated using a linear regression model...
February 13, 2023: Travel Medicine and Infectious Disease
https://read.qxmd.com/read/36792021/shigellosis-in-southeast-asia-a-systematic-review-and-meta-analysis
#13
REVIEW
Basilua Andre Muzembo, Kei Kitahara, Debmalya Mitra, Ayumu Ohno, Januka Khatiwada, Shanta Dutta, Shin-Ichi Miyoshi
BACKGROUND: Southeast Asia is attractive for tourism. Unfortunately, travelers to this region are at risk of becoming infected with Shigella. We conducted a meta-analysis to provide updates on Shigella prevalence in Southeast Asia, along with their serogroups and serotypes. METHODS: We conducted a systematic search using PubMed, EMBASE, and Web of Science for peer-reviewed studies from 2000 and November 2022. We selected studies that detected Shigella in stools by culture or polymerase chain reaction (PCR)...
February 13, 2023: Travel Medicine and Infectious Disease
https://read.qxmd.com/read/36758806/nasal-swab-is-a-good-alternative-sample-for-detecting-sars-cov-2-with-rapid-antigen-test-a-meta-analysis
#14
JOURNAL ARTICLE
Jia-Wen Xie, Ya-Wen Zheng, Mao Wang, Yong Lin, Yun He, Li-Rong Lin
BACKGROUND: We aim to determine if nasal samples have equivalent detection sensitivity to nasopharyngeal swabs for RAT and evaluate the diagnostic accuracy of nasal swabs with RAT. METHODS: PubMed and Web of Science were searched for eligible studies published before August 23, 2022. A bivariate random effects model was used to perform the quantitative synthesis. RESULTS: The pooled sensitivity, pooled specificity, positive likelihood ratio, negative likelihood ratio, and summary AUC on nasal swabs with RAT were 0...
February 7, 2023: Travel Medicine and Infectious Disease
https://read.qxmd.com/read/36754340/mrna-vaccines-as-an-armor-to-combat-the-infectious-diseases
#15
LETTER
Priyanka, Hitesh Chopra, Om Prakash Choudhary
No abstract text is available yet for this article.
February 6, 2023: Travel Medicine and Infectious Disease
https://read.qxmd.com/read/36746267/monkeypox-virus-mpxv-genomics-a-mutational-and-phylogenomic-analyses-of-b-1-lineages
#16
JOURNAL ARTICLE
Nicolas Luna, Marina Muñoz, D Katterine Bonilla-Aldana, Luz H Patiño, Yana Kasminskaya, Alberto Paniz-Mondolfi, Juan David Ramírez
The recent increase in monkeypox (MPX) cases has attracted attention of public health authorities due to its quick spread and transmission across non-endemic regions. This outbreak, unlike previous ones, displays different epidemiological features and transmission dynamics, which appear to be largely influenced by the newly divergent MPX lineages (B.1). Yet, the genomic characteristics driving the high dispersal and diversification of these lineages remain largely unknown. Herein, we sought to explore and characterize the genomic features and phylogenetic diversity of the B...
February 4, 2023: Travel Medicine and Infectious Disease
https://read.qxmd.com/read/36746266/first-human-infection-with-cryptosporidium-erinacei-xiiib-a-case-report-from-denmark
#17
LETTER
Tine Graakjær Larsen, Jonas Kähler, Marianne Lebbad, Huma Aftab, Luise Müller, Steen Ethelberg, Lihua Xiao, Christen Rune Stensvold
No abstract text is available yet for this article.
February 4, 2023: Travel Medicine and Infectious Disease
https://read.qxmd.com/read/36740087/sharp-decrease-in-malaria-incidence-among-the-french-armed-forces-in-french-guiana
#18
JOURNAL ARTICLE
Guillaume Velut, Franck de Laval, François Delon, Albane d'Oléon, Maylis Douine, Emilie Mosnier, Bakridine Mmadi Mrenda, Aissata Dia, Lise Musset, Sébastien Briolant, Vincent Pommier de Santi
No abstract text is available yet for this article.
February 3, 2023: Travel Medicine and Infectious Disease
https://read.qxmd.com/read/36716907/what-could-drive-the-re-emergence-of-infectious-diseases-in-a-post-covid19-era
#19
LETTER
Leidon Shapo, Edmond Puca
No abstract text is available yet for this article.
January 27, 2023: Travel Medicine and Infectious Disease
https://read.qxmd.com/read/36682574/chikungunya-in-returning-travellers-from-bali-a-geosentinel-case-series
#20
LETTER
Anna Britta Mayer, Paul-Henri Consigny, Martin P Grobusch, Daniel Camprubí-Ferrer, Ralph Huits, Camilla Rothe
No abstract text is available yet for this article.
January 19, 2023: Travel Medicine and Infectious Disease
journal
journal
40814
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.